The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $277,057 Phase I Small Business Innovation Research (SBIR) grant (CFDA 93.173) to Qualia Oto, Inc. to assess the viability of shape-adaptive cochlear implant (CI) electrode arrays. The goal is to develop a new solution for achieving atraumatic cochlear implantation and optimal electrode positioning simultaneously. The project will involve fabricating shape-memory polymer-inlaid, self-curling CI arrays,...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $306,073 to Iotamotion, Inc. to develop a navigation-based cochlear implant insertion system. The system is designed to optimize the trajectory and control the speed of electrode array insertion during cochlear implantation procedures, with the goal of preserving inner ear structures and...
Qualia Oto, Inc. was awarded a $233,928 Project Grant from the National Science Foundation to develop matrix-addressed, thin-film cochlear implant electrode arrays. The NSF funding supports a Small Business Technology Transfer Phase I project under the Technology, Innovation, and Partnerships program. The award will enable Qualia Oto to establish the feasibility of a novel circuit design fabricated on a thin-film platform using standard manufacturing equipment. Prototypes will undergo electrical...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173) will support research on perceptual adaptation and speech perception following cochlear implantation. The $682,911 award to New York University School of Medicine will fund a 5-year study aimed at understanding the nature, extent, and potential limitations of the adaptation process that...
This $149,184 federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will investigate methods for improving perception of vocal prosody for individuals with cochlear implants. The key products and services to be delivered include: Comparing perception of prosodic focus between listeners with normal hearing and cochlear implants, using a multiple...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $674,021 to the Massachusetts Eye and Ear Infirmary to advance the development of an implantable microphone technology for totally-implantable cochlear implants (TICI). The project aims to refine and test a novel implantable microphone design called the UMIC, which senses motion of...
This $377,700 Project Grant award, funded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), aims to develop and validate a clinical decision support tool (e.g. prediction model) for early risk stratification of cochlear implant (CI) speech perception performance. The research will integrate novel biomarkers, including electrocochleography and patient comorbidities, and...
The National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173), awarded a $417,741 project grant to the Massachusetts Institute of Technology (MIT) to develop computational models that replicate human auditory abilities. The goal is to improve prosthetic devices and therapeutic interventions for individuals with hearing impairment, cochlear implants, and auditory...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will provide $251,856 to investigate the neuroplasticity and early adaptations that occur in the brains of adult cochlear implant users. The research will be conducted at New York University Langone Medical Center and will expand the recipient's skillset in longitudinal studies of human...
The Project Grant award R43DC021615 was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173). The $275,371 award to Auricle Health Inc. in Oakland, CA will fund the development of an extracochlear device to restore high-frequency hearing for patients with sensorineural hearing loss, a condition affecting over 460 million people worldwide. In Phase I, the...